ShareValue scores for 603567.SHG: Valuation 54, Quality 31, Growth 18, Health 30.

603567.SHG
SSE

Heilongjiang ZBD Pharmaceutical Co Ltd

CN¥7.08(+9.94%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

1% to 16%
Valuation
54
Fair Value
Price vs Value
Quality
31
Weak
Business Strength
Growth
18
Weak
Revenue & Earnings
Health
30
Stressed
Financial Stability
Momentum
12
Bearish
Price Trend

Company Details

About

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the pharmaceuticals business in China. The company researches, develops, produces, and sale traditional Chinese medicine preparations, biological agents, and chemical agents, as well as involved in the pharmaceutical and Chinese medicinal materials trade; and leasing business. It also engages in pharmaceutical manufacturing; contract manufacturing of pharmaceuticals; pharmaceutical retail and wholesale; testing and inspection services; pharmaceutical internet information services; laboratory animal production; and laboratory animal management. The company offers medicines in the field of cardiovascular and cerebrovascular, anti-infectives, respiratory system drugs, tumors, and antiviral drugs diseases. Heilongjiang ZBD Pharmaceutical Co., Ltd. was founded in 1996 and is based in Harbin, China. Address: No. 8, Yantai Road, Harbin, China, 150060

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026